Comparative analysis of biochemical parameters of atherosclerosis adiponectin and resistin in patients with diabetes mellitus and coronary heart disease

D. Rasic ,
D. Rasic
V. Peric ,
V. Peric
J. Rasic ,
J. Rasic
S. Lazic ,
S. Lazic
G. Nikolic ,
G. Nikolic
B. Dejanovic
B. Dejanovic

Published: 01.08.2015.

Volume 44, Issue 3 (2015)

pp. 7-13;

https://doi.org/10.5937/pramed1503007r

Abstract

The most important adipocytokines affecting the formation and the regression of atheromas plaque in the coronary blood vessels are adiponectin and resistin. The essence of this test is to determine the correlation of the leading biochemical parameters of atherosclerosis, adiponectin and resistin and determine their interdependence with other biochemical parameters in patients with diabetes mellitus and coronary heart disease. Our study group consisted of 140 patients and 40 control group (healthy), 50 with diabetes mellitus and 50 with coronary heart disease (myocardial infarction and angina pectoris). We find that the average value of adiponectin in the group with type 2 diabetes mellitus were significantly lower than in the control group (4.38 to 6.74, p = 0.001, p <0.05). In the same study group average value of resistin was significantly higher than in the control group (15.8 to 7.88, p <0.001). The average value of adiponectin and resistin in patients with myocardial infarction and angina pectoris are no different from the value obtained in diabetes mellitus (4.94 to 4.38 and p = 0.397, p> 0.05). In the same study group average value of resistin was significantly higher than in the control group (15.73 to 7.88, p = 0.001, p <0.01) and not different than in the group with diabetes mellitus. Values Pearsonovg correlation coefficient shows that the biggest falls inversely proportional dependence of adiponectin with a simultaneous increase in resistin is expressed in patients with myocardial infarction, which is expressed very good correlation coefficient (-0.36). In all the groups, shows that there is a negative correlation between resistin and adiponectin, with increasing values of resistin values of adiponectin are reduced.

Keywords

References

1.
Salmenniemi U, Ruotsalainen E, Pihlajamaki J, Vauhkonen I, Kainulainen S, Punnonen K. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation. 2004;(25):3842–8.
2.
Goldstein B, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab. 2004;(6):2563–8.
3.
Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 2004;(6):1318–23.
4.
Schulze M, Shai I, Rimm E, Li T, Rifai N, Hu F. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes. 2005;(2):534–9.
5.
Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006;515–81.
6.
Otake H, Shite J, Shinke T, Watanabe S, Tanino Y, Ogasawara D, et al. Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome. Am J Cardiol. 2008;1–7.
7.
Originalni Radovi.
8.
Huang C, Wu Y, Wu C, Lin L, Wu Y, Hsu P, et al. Association between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary artery disease. Cardiovasc Diabetol. 2013;105.
9.
Persson J, Lindberg K, Gustafsson T, Eriksson P, Paulsson-Berne G, Lundman P. Low plasma adiponectin concentration is associated with myocardial infarction in young individuals. J Intern Med. 2010;194–205.
10.
Lee S, Park E, Kim S, E, Yoon S, Ahn Y, et al. Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis. Int J Epidemiol. 2013;1029–39.
11.
Yamawaki H, Kameshima S, Usui T, Okada M, Hara Y. A novel adipocytokine, chemerin exerts anti-inflammatory roles in human vascular endothelial cells. Biochem Biophys Res Commun. 2012;152–7.
12.
Okamoto Y, Ishii S, Croce K, Katsumata H, Fukushima M, Kihara S, et al. Adiponectin inhibits macrophage tissue factor, a key trigger of thrombosis in disrupted atherosclerotic plaques. Atherosclerosis. 2013;373–7.
13.
Van De Voorde J, Pauwels B, Boydens C, Decaluwé K. Adipocytokines in relation to cardiovascular disease. Metabolism. 2013;1513–21.
14.
Nakamura K, Fuster J, Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol. 2014;250–9.
15.
Kim J, Choi E, Mun H, Min P, Yoon Y, Lee B, et al. Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines. Cardiovasc Diabetol. 2013;140.
16.
Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart. 2004;528–33.
17.
Zhang H, Mo X, Hao Y, Huang J, Lu X, Cao J, et al. Adiponectin levels and risk of coronary heart disease: a meta-analysis of prospective studies. Am J Med Sci. 2013;455–61.
18.
Basati G, Razavi A, Abdi S, Sarrafzedegan N. Association of plasma leptin, homocysteine and nitric oxide levels with the presence and unstability of coronary artery disease. Biomark Med. 2014;405–12.
19.
Ntaios G, Gatselis N, Makaritsis K, Dalekos G. Adipokines as mediators of endothelial function and atherosclerosis. Atherosclerosis. 2013;216–21.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by